Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
231.1 EUR | -1.32% | -3.94% | -18.82% |
06-28 | Would you like some more inflation? | |
06-28 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GENMAB A/S | Bio Therapeutic Drugs | -1.32% | -3.94% | - | - | - | 15.91B | - | - | - |
- Stock Market
- Equities
- GMAB Stock
- GE9 Stock
- Charts Genmab A/S
- Relative Strength Chart